Industries · Medical device sales · Missouri
Medical device sales leads in Missouri
Catch new facilities, ownership changes, and hospital capital-equipment spending jumps as they hit the record.
This page scopes the same official-record Parses to Missouri — the sample below is a live slice of the feed filtered to MO.
Medical device sales · Missouri
LiveNew 510(k) / PMA device clearances, national
ParseData signals · Missouri · updated daily
Sample dataset
Real Missouri rows from the feed
A live slice of the public-record feed behind this vertical, filtered to Missouri. Rows report counts and statuses as recorded — observational public records, not a consumer report, no FCRA use.
| decision_date | applicant | device_name | specialty | product_code | pathway | state |
|---|---|---|---|---|---|---|
| 2026-08-27 | Geneoscopy, Inc. | ColoSense® | Pathology | SBB | pma | MO |
| 2026-08-27 | Stereotaxis, Inc. | GenesisX RMN | Cardiovascular | DXX | 510k | MO |
| 2026-08-19 | C2N Diagnostics, LLC | PrecivityAD2 Test | Immunology | SET | 510k | MO |
| 2026-07-31 | Stereotaxis, Inc. | MAGiC Ablation Catheter | Cardiovascular | LPB | pma | MO |
| 2026-07-27 | Plus EV Holdings, Inc. D/B/A Intimate Rose | Intimate Rose Pelvic Wand (Purple); Intimate Rose Bendable Pelvic Wand (Orange); Intimate Rose Temperature Pelvic Wand (Yellow) | Physical Medicine | OSD | 510k | MO |
| 2026-07-08 | bioMerieux, Inc. | VITEK REVEAL GN AST Assay and VITEK REVEAL AST System | Microbiology | SAN | 510k | MO |
| 2026-06-10 | Medibeacon, Inc. | MediBeacon® Transdermal GFR Measurement System (TGFR) | Gastroenterology, Urology | SDK | pma | MO |
| 2026-05-15 | Bausch and Lomb | Stellaris Elite vision enhancement system; Posterior and Combined Procedure Pack(s): 23 ga. Posterior Elite Pack (SE5423); 23 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5423B); 25 ga. Posterior Elite Pack (SE5425); 25 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5425B); 27 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5427B); 23 ga. Bi-Blade+ Vitreous Cutter Posterior Stellaris Elite Pack (SE5423BB+); 25 ga. Bi-Blade+ | Ophthalmic | HQC | 510k | MO |
| 2026-04-15 | bioMerieux, Inc. | VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance | Microbiology | LON | 510k | MO |
| 2026-04-01 | Stereotaxis, Inc. | Synchrony | Cardiovascular | DQK | 510k | MO |
| 2026-03-26 | BIOMERIEUX | VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) | Microbiology | LON | 510k | MO |
| 2026-03-25 | Bausch and Lomb, Incorporated | Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565, SE14565E, SE15565E) | Ophthalmic | HQC | 510k | MO |
| 2026-01-05 | Stereotaxis, Inc. | MAGiC Ablation Catheter | Cardiovascular | LPB | pma | MO |
| 2025-12-15 | Medibeacon, Inc. | MediBeacon® Transdermal GFR Measurement System (TGFR) | Gastroenterology, Urology | SDK | pma | MO |
| 2025-12-05 | Remvia | Remvia NightGuard | Unknown | MQC | 510k | MO |
Live sampleReal openFDA 510(k) clearances and PMA approvals — newly cleared devices and their manufacturer, newest-first, the day-one target list a device line sells into. Swap the feed and filters on /build. Filtered to Missouri.
Prebuilt Parses
Medical device sales Parses you can scope to Missouri
Each links to the builder with the Parse preloaded — set the state to MO, edit the events or cadence, and subscribe.
New 510(k) / PMA device clearances, national
MO · daily
New cardiovascular device clearances, weekly
MO · weekly
Hospital capex jumps, national, daily
MO · daily
Facility ownership changes (CHOW), nationwide weekly
MO · weekly
Capex + CHOW, Northeast corridor
MO · daily
Hospitals reporting capex jumps in my region
MO · daily
Capex jumps across the Southeast
MO · daily
New providers + capex signals, California
MO · daily
Other states
Medical device sales in other states
Subscribe to a medical device sales Parse in Missouri
Whenever a new company in Missouri fits your Parse, we notify you — by email, webhook, or Zapier. Start from a prebuilt example above or build your own.